Ausgabe 6/2005
Inhalt (11 Artikel)
Executive function improvement upon remission of recurrent unipolar depression
E. Biringer, A. Lundervold, K. Stordal, A. Mykletun, J. Egeland, R. Bottlender, A. Lund
Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients
A. Saffet Gonul, F. Akdeniz, F. Taneli, O. Donat, Ç. Eker, S. Vahip
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
M. Adli, Ch. Baethge, A. Heinz, N. Langlitz, M. Bauer
Volume deficits of subcortical nuclei in mood disorders
H. Bielau, K. Trübner, D. Krell, M. W. Agelink, H.–G. Bernstein, R. Stauch, C. Mawrin, P. Danos, L. Gerhard, B. Bogerts, B. Baumann
Intact and deficient feature fusion in schizophrenia
A. Brand, S. Kopmann, S. Marbach, M. Heinze, M. H. Herzog
Two types of classification for male opioid dependence: Identification of an opioid addict with depressive features
J. Modestin, B. Matutat, O. Würmle
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD
J. Krause, Ch. la Fougere, K.-H. Krause, M. Ackenheil, St. H. Dresel
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms
M. Riedel, N. Müller, M. Strassnig, I. Spellmann, R. R. Engel, R. Musil, S. Dehning, A. Douhet, M. J. Schwarz, H.–J. Möller
Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters
J. Brunner, Th. Bronisch, M. Uhr, M. Ising, E. Binder, F. Holsboer, C. W. Turck